miRNAs as Cancer Biomarkers
Publisher
Springer New York
Reference170 articles.
1. Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J Intern Med. 2007;18(3):175–84.
2. Roulston JE. Limitations of tumour markers in screening. Br J Surg. 1990;77(9):961–2.
3. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, Galas DJ, Wang K. The microRNA spectrum in 12 body fluids. Clin Chem. 2010;56(11):1733–41.
4. Hayes DF, Bast RC, Desch CE, Fritsche Jr H, Kemeny NE, Jessup JM, Locker GY, Macdonald JS, Mennel RG, Norton L, et al. Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst. 1996;88(20):1456–66.
5. Bence-Jones H. Papers on chemical pathology. Lecture III. Lancet. 1847;ii:269–72.